Biotop-report 2013

65

BioTOPics 46 | September 2013 

BioTOP-Report

 

Biotech Companies

Botiss medical AG

Botiss biomaterials is a privately owned biotech company, headquartered in Berlin. botiss 

is the leading German specialist for dental bone and tissue regeneration (BTR). We focus on 

the development of innovative regenerative materials and clinical marketing / distribution 

in over 50 countries world-wide. The botiss subsidiary Cell+Tissue Bank Austria is a leading 

European manufacturer of allogenic materials for hard tissue regeneration.

botiss.com

Breecon GmbH

The breecon GmbH is an innovative service company in life science with focus on green 

biotechnology. The objectives of the company are consulting, application and mediation 

of biotechnological-analytical services as well as their development and marketing. The 

breecon GmbH offers his services to plant breeders and companies of the industrial bio-

technology and supports the utilization of genetic diversity in the context of SMART breed-

ing.

breecon.com

BST Bio Sensor Technology GmbH

BST develops and produces biosensors to provide high quality analysis at moderate prices. 

In 1982 BST brought on the market the first multi-way biosensor based blood glucose 

analyzer in Europe and is since then market leader in Europe. Today BST sells more than 

60.000 sensors a year. Since 2008 BST is besides biosensors also manufacturer of POCT 

and laboratory instruments.

bst-biosensor.de

Caprotec bioanalytics GmbH

Caprotecs Capture Compound Mass Spectrometry (CCMS) Technology allows separation 

and isolation of proteins based on functionality. For many applications, CCMS is clearly 

superior to conventional methods - thus addressing an unmet need in the proteomics 

research community. The company is commercializing the CCMS technology through Im-

proMed projects with pharmaceutical and biotechnology companies. The focus on these 

collaborations is on investigating mechanisms of drug action (MoA) and identification of 

on- and off-target proteins to understand potential adverse effects of drug candidates on 

a molecular level. This can be easily carried out in the lead optimization process, or even 

earlier to increase the probability of success later on in the clinic.

caprotec.com

Capsulution Pharma AG

Capsulution Pharma AG develops innovative nano- and micron-sized capsules. The com-

pany applies its worldwide-patented so-called LBL-Technology

®

. Based on their minute 

size, their functionality and their highly reproducible production process the capsules can 

be used for a multitude of different applications. Accordingly, the precisely sized capsules 

(500 nm to 50 µm) can be made to function in a manner to suit the intended application, 

and can be given the appropriate biochemical, electrical, optical and magnetic properties 

as required by the customer.

capsulution.com

Celares GmbH

Specialist for Drug Delivery of peptides/proteins by using PEGylation. Modification of 

Biopharmaceuticals with polyethylene glycol in order to substantially improve pharma-

cological properties. Offers the unique CelaSYS-PEGylation technology, which is patented 

by celares. CelaSYS: non-dispersed, highly branched polyethylene glycol based reagents. 

Additionally celares offers customized PEGylation solutions as well as synthesis of custom-

ized PEG-reagents.

celares.com

CellServe GmbH

CellServe is a service provider for research groups in regenerative medicine and fills an 

important gap in the conversion of applied treatment concepts from research into mar-

ketable products. Furthermore CellServe develops own innovative cell-based products for 

cardiology and uses novel cardiac derived cells ("From the Heart to the Heart") for the 

treatment of chronic heart failure. 

cellserve.de

CellTrend GmbH

Celltrend is certified according to ISO 9001, ISO 13485 and GMP Cell culture systems for 

research on active substances (bioassays, preclinical research, for quality control)Develop-

ment and production of antibody-based detection systems (ELISA) Chemosensitivityassay 

for optimisation of chemotherapy (tumor patients).

celltrend.de

Chemicell GmbH

Chemicell develops and produces magnetic, fluorescent and coloured nano- and micropar-

ticles, reactive fluorescent dyes and special chromatography-materials for the separation or 

detection of cells, bacteria, viruses, proteins or DNA/RNA and new gene transfer systems.

chemicell.com

Chipron GmbH

Chipron GmbH specializes in production and distribution of array based detection systems 

for DNA/pathogens.

chipron.com

CHIRACON GmbH

chiracon is a qualified partner to develop chiral intermediates at a constant high qual-

ity for innovative drugs regarding economic, environmentally acceptable and scaleable 

aspects. We offer support through expert knowledge and key technology to meet your 

increasing needs. Our core competence is chirality. In addition we have a broad variety 

of chiral building blocks as an inhouse raw material source for high-level API production 

and development.

chiracon.de

CMZ-Assay GmbH

Marketing of diagnostic reagents for measuring concentrations of proteins, hormones and 

their isoforms, exclusively for research purposes.

cmz-assay.com

co.don

®

 AG

co.don

®

 AG is one of the leading biopharmaceutical companies in the area of Regenerative

Medicine/Tissue Engineering. Since 1997, co.don

®

 AG has developed, manufactured and

distributed human Tissue engineering therapeutics for the regeneration of articular carti-

lage and intervertebral discs.

codon.de

---